Q4 2023 update: M&A activity in pharmaceutical in Middle East and Africa
In the Middle East and Africa pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total…
In the Middle East and Africa pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total…
In the South and Central America pharmaceutical industry, there were 5 M&A deals announced in Q4 2023, worth a total…
In the Italian pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total value of $6.9bn,…
In the European pharmaceutical industry, there were 87 M&A deals announced in Q4 2023, worth a total value of $9.2bn,…
In the German pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total value of $45m,…
In the Asia-Pacific pharmaceutical industry, there were 104 M&A deals announced in Q4 2023, worth a total value of $16.1bn,…
In the North American pharmaceutical industry, there were 228 M&A deals announced in Q4 2023, worth a total value of…
In the Chinese pharmaceutical industry, there were 29 M&A deals announced in Q4 2023, worth a total value of $3.5bn,…
In the Australian pharmaceutical industry, there were 6 M&A deals announced in Q4 2023, worth a total value of $276.3m,…
In the US pharmaceutical industry, there were 210 M&A deals announced in Q4 2023, worth a total value of $64.6bn,…